Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

DMAAU

Drugs Made In America Acquisition Corp.

CIK 0002028614 · Nasdaq

NasdaqFinancialsBlank Checks
$10.72
↑ 0.00 (0.00%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BearishOverall score · based on 2/4 lenses
FundamentalsOwnershipTechnicalsOptions

Risks: Fundamentals; Excluded: Ownership, Options (no data)

Key stats

Market Cap
$260.25M
P/E Ratio
39.10
EPS
Not covered
Dividend Yield
Not covered
52W Position
19%
Beta
0.12

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
-35.28
P/S
Not covered
EV/Revenue
Not covered
ROE
-90.2%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 19%
$10.30$12.50

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
$5.94M
Total Assets
$239.92M
Free Cash Flow
–

Recent news